Job offer Detail

Home /

Biomarker Strategy Lead

2026-02-24

Full time

Temporary

Gi Group co-branding

Clinical Biomarker Strategy Lead (Temporary Assignment)


Key Responsibilities

Strategic & Scientific Leadership

  • Act as the scientific, strategic, and tactical Biomarker Development (BMD) lead at the project level, shaping and driving impactful biomarker strategies.
  • Translate disease biology and mechanistic insights into clinically relevant, actionable biomarker plans.
  • Lead biomarker and diagnostic discussions within project teams and deliver high‑quality input at governance meetings.

Biomarker Strategy & Execution

  • Own the biomarker strategy across project, indication, and study levels.
  • Collaborate with clinical study leads and biomarker experts to design and implement fit‑for‑purpose biomarker solutions.
  • Guide endorsement, execution, and interpretation of biomarker activities spanning multiple modalities (genetic, genomic, soluble, cellular, imaging, digital).

Cross‑Functional Leadership

  • Lead and coordinate a matrixed group of biomarker scientists, clinical partners, and cross‑functional stakeholders.
  • Represent BMD in therapeutic area committees and contribute to clinical protocol development and operational milestone reviews.
  • Partner with research, translational data science, and clinical development colleagues to enable biomarker‑driven decision‑making.

Scientific Communication

  • Interpret and contextualize biomarker results and communicate findings through abstracts, presentations, and peer‑reviewed publications.
  • Identify, evaluate, and advocate for innovative biomarker technologies to support clinical differentiation and optimize patient selection.


Qualifications & Experience

  • MD, MD/PhD, or PhD with postdoctoral or equivalent research experience.
  • At least 5 years of industry experience in Pharma or Biotech.
  • Strong scientific or clinical expertise in immunology or immune‑mediated diseases.
  • Proven track record in translational science and biomarker strategy in early and/or late clinical development.
  • Experience applying biomarkers to support clinical decision‑making (pharmacodynamics, efficacy, disease deconvolution, response characterization, patient stratification, precision medicine).
  • Demonstrated ability to interpret and communicate omics‑based data (genomics, genetics, proteomics) in a clinical context.
  • Strong experience working in global, cross‑functional matrix teams with excellent communication and influencing skills.
  • Ability to balance strategic vision with detailed execution, combined with scientific curiosity and an innovative mindset.
  • Skilled at engaging KOLs and external stakeholders.
  • Fluent in English; additional languages such as German, French, or Italian are an advantage.




Biopharmaceutical

Pharmaceutical And Biotechnology

9968

Basel - Basel-Stadt




Biomarker Strategy Lead
Temporary / Basel
Location:
Basel
Industrial sector:
Biopharmaceutical
Professional area:
Pharmaceutical And Biotechnology
Number of vacancies:
1
Reference code:
9968
Job offer insertion date:
2026-02-24

Clinical Biomarker Strategy Lead (Temporary Assignment)


Key Responsibilities

Strategic & Scientific Leadership

  • Act as the scientific, strategic, and tactical Biomarker Development (BMD) lead at the project level, shaping and driving impactful biomarker strategies.
  • Translate disease biology and mechanistic insights into clinically relevant, actionable biomarker plans.
  • Lead biomarker and diagnostic discussions within project teams and deliver high‑quality input at governance meetings.

Biomarker Strategy & Execution

  • Own the biomarker strategy across project, indication, and study levels.
  • Collaborate with clinical study leads and biomarker experts to design and implement fit‑for‑purpose biomarker solutions.
  • Guide endorsement, execution, and interpretation of biomarker activities spanning multiple modalities (genetic, genomic, soluble, cellular, imaging, digital).

Cross‑Functional Leadership

  • Lead and coordinate a matrixed group of biomarker scientists, clinical partners, and cross‑functional stakeholders.
  • Represent BMD in therapeutic area committees and contribute to clinical protocol development and operational milestone reviews.
  • Partner with research, translational data science, and clinical development colleagues to enable biomarker‑driven decision‑making.

Scientific Communication

  • Interpret and contextualize biomarker results and communicate findings through abstracts, presentations, and peer‑reviewed publications.
  • Identify, evaluate, and advocate for innovative biomarker technologies to support clinical differentiation and optimize patient selection.


Qualifications & Experience

  • MD, MD/PhD, or PhD with postdoctoral or equivalent research experience.
  • At least 5 years of industry experience in Pharma or Biotech.
  • Strong scientific or clinical expertise in immunology or immune‑mediated diseases.
  • Proven track record in translational science and biomarker strategy in early and/or late clinical development.
  • Experience applying biomarkers to support clinical decision‑making (pharmacodynamics, efficacy, disease deconvolution, response characterization, patient stratification, precision medicine).
  • Demonstrated ability to interpret and communicate omics‑based data (genomics, genetics, proteomics) in a clinical context.
  • Strong experience working in global, cross‑functional matrix teams with excellent communication and influencing skills.
  • Ability to balance strategic vision with detailed execution, combined with scientific curiosity and an innovative mindset.
  • Skilled at engaging KOLs and external stakeholders.
  • Fluent in English; additional languages such as German, French, or Italian are an advantage.



https://ch.gigroup.com/job-offer-detail/basel-basel-stadt-biomarker-strategy-lead/?jobid=9968